撕掉肿瘤细胞“隐身衣”，攻克癌症免疫耐受难题有新突破

Group 1 - The core issue in cancer research is that some tumor cells can evade the immune system, making traditional immunotherapy ineffective [1] - A research team from Peking University has developed a protein-targeted degradation technology that forces hidden tumor cells to reveal themselves, providing a new approach to overcoming cancer immune tolerance [1] Group 2 - Relevant A-share concept stocks include Innovent Biologics and Hecolin Pharmaceutical [2]